EPIVX | VIHAX | EPIVX / VIHAX | |
Total Expense Ratio | 1.73 | 0.17 | 1,018% |
Annual Report Gross Expense Ratio | 1.73 | 0.17 | 1,018% |
Fund Existence | 15 years | 9 years | - |
Gain YTD | 20.356 | 17.047 | 119% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 153M | 11B | 1% |
Annual Yield % from dividends | 1.55 | 4.14 | 37% |
Returns for 1 year | 23.54 | 17.16 | 137% |
Returns for 3 years | 39.63 | 37.64 | 105% |
Returns for 5 years | 66.96 | 64.92 | 103% |
Returns for 10 years | 84.64 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
URA | 38.71 | 0.87 | +2.30% |
Global X Uranium ETF | |||
CGV | 13.59 | 0.20 | +1.47% |
Conductor Global Equity Value ETF | |||
QQQS | 26.89 | 0.32 | +1.20% |
Invesco NASDAQ Future Gen 200 ETF | |||
BCX | 9.36 | 0.11 | +1.19% |
Blackrock Resources & Commodities Strategy Trust | |||
CAML | 36.04 | 0.34 | +0.95% |
Congress Large Cap Growth ETF |